2027 call · applications from 27 October 2026 to 7 March 2027

Strong innovation ecosystems, better health in Latam

A regional initiative that identifies, boosts and showcases innovative solutions in the health sector in Latin America.

Opening 27 Oct 2026
Applications close 7 Mar 2027
Regional reach
323innovations registered, 2024–2026
19recognized solutions
12countries with registered innovations

Innovations and countries: program registration database, 2024–2026 editions.

Select a country on the map to see its innovations.

Opening soon

Applications open in

The Latam Health Champions 2027 call accepts applications from 27 October 2026 to 7 March 2027.

00days
00hours
00min
00sec
    Bogotá time (UTC−5). Closes at 23:59 on 7 March. Apply to the 2027 edition
    Profiles

    Who are we looking for?

    We are looking for health solutions developed in Latin America that meet a real need of patients and health systems and make strategic use of intellectual property. The call is open to hospitals and clinics, research centers, universities, start-ups and SMEs and other actors in the Latin American health innovation ecosystem.

    Hospitals and clinics

    Care teams that turn needs from clinical practice into devices, processes or services.

    Research and R&D centers

    Groups that take research results toward applicable health solutions.

    Universities

    Academic developments with potential for technology transfer and partnerships with industry.

    Start-ups and SMEs

    Technology-based companies with a health product or service in development or on the market.

    And other actors in the Latin American health innovation ecosystem with an innovative solution and an applied intellectual property strategy.

    Types of solution
    Software and platformsMedical deviceHybrid solutionBiotechnology and therapiesMethodology or processService
    How applications are evaluated

    A panel of experts evaluates each application against these criteria:

    1. Need
    2. Novelty
    3. Impact
    4. Scalability
    5. Use of intellectual property
    Before you apply
    • Identify the intellectual property assets of your solution: patents, designs, software, trademarks or trade secrets.
    • Do not include confidential information. Premature disclosure may affect the novelty of a future patent.
    • Read the 2027 Terms of Reference before applying.
    How it works

    Four stages per edition

    01

    Call

    Seeks actors in the Latin American health innovation ecosystem.

    02

    Evaluation

    By a panel of experts, considering five criteria: need, novelty, impact, scalability and use of intellectual property.

    03

    Support

    Intellectual property mentoring with academic partners, a mission to the Boston ecosystem, communications mentoring and an intellectual property course.

    04

    Publication

    We publish the results of each edition and the solutions in the directory to identify challenges, support their development and strengthen health innovation in Latin America.

    Track record

    Three editions completed, the fourth under way

    Application and recognition figures for each call.

    2024
    First edition
    IDENTIFY
    55applications
    20finalists
    3winners
    9countries
    2025
    Second edition
    STRENGTHEN
    178applications
    32finalists
    8winners
    11countries
    2026
    Third edition
    CONNECT
    234applications
    21finalists
    8winners
    11countries
    2027Ongoing
    Fourth edition
    SCALE
    Opencall
    16 Marwinners announced
    FAQ

    What you need to know to apply

    A summary of the key conditions. The full rules are in the “2027 Terms of Reference” tab at the end of the list.

    coordinacion@innos.co
    Who can apply?

    R&D&I centers, universities, hospitals, clinics, start-ups, SMEs and other actors in the Latin American health innovation ecosystem, legally incorporated in a country of the region, with an innovative health solution and a clear applied intellectual property strategy.

    When can I apply?

    From 27 October 2026 to 7 March 2027 at 23:59, Bogotá time (UTC−5). Winners are announced on 16 March 2027.

    How are applications evaluated?

    Against five criteria: need, novelty, impact, scalability and use of intellectual property.

    What do winning solutions receive?

    Up to five winners are selected. They receive a mission to a U.S. innovation ecosystem (Boston, April 2027), virtual intellectual property mentoring, dissemination of their case, and participation in the closing event and the communication kit.

    Who travels on the Boston mission?

    One representative per winning organization, who must hold a valid visa to travel to the United States.

    Should I include confidential information?

    No. Describe your solution without disclosing confidential information: premature disclosure may affect the novelty of a future patent.

    Where can I get answers to my questions?

    Write to coordinacion@innos.co, the official channel for the call.

    2027 Terms of Reference

    Requirements, conditions, benefits, evaluation criteria and timeline for the Latam Health Champions 2027 call.

    Organizers
    • FIFARMA — Latin American Federation of the Pharmaceutical Industry
    • INNOS — Institute for Health Foresight and Innovation
    • UEB — Universidad El Bosque
    • UNC — Universidad Nacional de Córdoba
    Intended for

    R&D&I centers, hospitals, clinics, universities, start-ups, small and medium-sized enterprises (SMEs) and other actors in the Latin American innovation ecosystem that have innovative solutions applied to the health sector and a clear applied intellectual property strategy.

    1What is Latam Health Champions?

    It is a program that seeks to bring together actors in the Latin American health innovation ecosystem with innovative solutions that address or solve problems/challenges in the health sector, in order to select up to 5 winners, who will be invited to take part in a Mission to the United States, to one of the most prominent innovation ecosystems in the world, and will receive specialized intellectual property mentoring.

    2Who can participate?

    R&D&I centers, universities, hospitals, clinics, start-ups, SMEs and other actors in the Latin American health innovation ecosystem. Participants must submit, through the application form (section 14), specific information about their innovative solution and the applied intellectual property strategy, on the basis of which the jury will carry out an analysis and select up to 5 winners.

    3What are the participation requirements?

    The requirements to participate are as follows:

    • Be legally incorporated as a legal entity in one of the countries of the region.
    • The team member who would attend the Mission (if selected) must hold a valid U.S. visa (2026–2027).
    • Have an innovative health development (device, software, accessory, equipment and technology in general) that solves a general or specific problem with an impact on people’s quality of life.
    • Eligible innovative solutions must be applied to the health sector and have a clear applied intellectual property strategy.
    4What are the general conditions of participation?

    The general conditions to participate are as follows:

    • Each actor in the health innovation ecosystem may participate in the Call with a maximum of one innovative solution (a single application).
    • The innovative solution submitted may not be replaced by another at any point in the program.
    • Participating actors in the health innovation ecosystem must guarantee the accuracy and truthfulness of the data and information they provide in the application and throughout the Call.
    • The right to participate in the Call is non-transferable.
    • Participants selected as winners must take part in the Call in its entirety.
    • Participating actors in the health innovation ecosystem must be available and respond promptly to requests for additional information and/or to attend the meetings/sessions scheduled during the Call.
    5What are the benefits?

    The 5 selected actors in the health innovation ecosystem will have access to the following benefits:

    • Participation in a Mission to the United States, to one of the most relevant innovation ecosystems.
    • Specialized virtual intellectual property mentoring.
    • Dissemination of the winning cases through the platforms and channels of the organizing institutions.
    • Participation in the closing event.
    • Inclusion in the initiative’s communication kit.
    Notes
    • For each winner, one (1) team member holding a valid U.S. visa may take part in the Mission.
    • The winners will have the opportunity to get to know one of the most important innovation ecosystems in the United States through a trip to Boston planned for April 2027.
    • The specific dates and destinations of the Mission are subject to change and will be announced once the winners are selected.
    6Intellectual property
    • The intellectual property rights associated with the innovative solution submitted must belong to the respective participant and/or have the corresponding third-party authorizations.
    • All intellectual property rights of participants over their innovative solutions will be respected and recognized at all times.
    • Each participant will be fully responsible for any intellectual property claim associated with their innovative solution.
    7Evaluation criteria
    CriterionDescriptionEvaluation
    NeedThe type of problem that the innovative health solution solves or seeks to solve will be evaluated, with higher scores given to solutions focused on global health problems over those that seek to solve specific issues.Higher scores will go to solutions that address problems and/or needs affecting a larger number of people and/or territories, that address prioritized health problems and current issues.
    ImpactThe type and scope of the impact the solution may have in terms of benefits for society will be evaluated.Higher scores will go to solutions that generate greater impact in terms of public benefits, serve vulnerable populations, improve the efficiency and effectiveness of health systems and address health problems in hard-to-reach areas.
    NoveltyThe novelty and/or differentiating factor of the solution in solving a previously unsolved problem, or the new way of solving a problem more efficiently and/or with greater population reach compared with existing solutions, will be evaluated.Under this criterion, higher scores will go to solutions with novel technical elements that improve the service, generate greater efficiency, lower costs and greater benefits for patients.
    ScalabilityThe current or potential scalability of the solution in terms of implementation in territories, regions, countries or globally will be evaluated.Higher scores will go to solutions with greater scalability —replicable in other countries at the regional or global level— and greater durability of the benefits generated.
    Intellectual propertyThe relationship between intellectual property and the innovative solution will be evaluated in terms of generation, use, securing of rights and commercialization. Innovative solutions must have a solid intellectual property strategy based on the use of one or more intellectual property mechanisms such as patents, trademarks, industrial designs, trade secrets and/or copyright.Higher scores will go to solutions with secured intellectual property —through contracts and/or registrations— that do not infringe third-party rights, whose business model makes strategic use of the intellectual property associated with the technological solution, and where there is current or potential exploitation of IP through commercialization mechanisms.
    8Winner selection process
    1. Receipt of applications: verification of compliance with requirements.
    2. Request for additional information (according to the needs of the application).
    3. Review and analysis of applications (pre-selection).
    4. Evaluation of pre-selected participants.
    5. Selection of up to 5 winners.
    6. Announcement of the winners.
    9Timeline
    ActivityDate
    Call opensOctober 27, 2026
    Call closesMarch 5, 2027
    Announcement of selected participantsMarch 16, 2027
    Mission to the United StatesNote: dates subject to availability/change.April 26–28, 2027
    10Data protection

    The organizing institutions and the participants undertake to properly handle/process the data accessed in connection with this Call, in accordance with their institutional data protection policies and national personal data protection legislation (Colombian Law 1581 of 2012 and other complementary regulations).

    11Confidentiality

    Participants must not include with their application any confidential information about their innovative solution, or any information whose disclosure would mean losing the opportunity to protect intellectual property.

    The information provided through the applications may be disclosed/published without restriction by the organizing institutions of Latam Health Champions, through any medium, for informational purposes.

    12Clarifications

    The organizing institutions of the Call will select up to 5 winners according to the evaluation of requirements, and reserve the right to exclude applications due to incompatibilities and/or the identification of possible improper use of third-party intellectual property rights.

    The organizing institutions of Latam Health Champions may make changes to the scope of the Call, which will be communicated to participants in a timely manner through the official website.

    13Questions and comments

    The only official channel for questions and comments will be the email address coordinacion@innos.co.

    Only communications sent through the official email address will be taken into account.

    14Application

    Actors in the health innovation ecosystem interested in participating must complete the application form available on the official website of the call.

    Applications will be considered formally received only through the designated form. Applications submitted by any other means will not be accepted.